Peer-reviewedLicence not statedThe journal of pain
Drug-opposite neuroadaptation and breakthrough pain
- 1Department of Anesthesiology and Pain Medicine, University of Washington School of Medicine, Seattle, WA, United States
- 2National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, Bethesda, MD, United States
Related
- Urine Drug Testing at an Ambulatory Pain Clinic in Patients Receiving Opioids for Cancer Pain †
- Drug exposure during oxycodone-S-ketamine patient-controlled analgesia reflects pain-related dosing behaviour after lumbar fusion surgery
- Patient Experiences of Access, Stigma, and Trust and Preferences for Non-Opioid Drug Delivery Systems in Chronic Pain Management.
- Trends in Opioid Prescribing for Nonspecific Low Back Pain After CDC Guidelines and California Prescription Drug Monitoring Programs, 2012-2024
- Sequential Opposite-pattern Supracondylar Fractures in the Same Elbow of a Child
BibTeX
@article{ballantyne2026drugopposite,
title = {{Drug-opposite neuroadaptation and breakthrough pain}},
author = {Jane C. Ballantyne and George F. Koob},
journal = {The journal of pain},
year = {2026},
month = aug,
doi = {10.1016/j.jpain.2026.106394},
url = {https://doi.org/10.1016/j.jpain.2026.106394},
}
RIS
TY - JOUR
TI - Drug-opposite neuroadaptation and breakthrough pain
AU - Jane C. Ballantyne
AU - George F. Koob
PY - 2026
DA - 2026/08/04
JO - The journal of pain
DO - 10.1016/j.jpain.2026.106394
UR - https://doi.org/10.1016/j.jpain.2026.106394
SN - 1526-5900
SN - 1528-8447
ER -